pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›GABAPENTIN
drug
save

GABAPENTIN

Marketedupdated 6mo ago
by ACI Healthcare USA Inc
Approved
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval240 co-mentions · 120 sources
  • drugGralise127 co-mentions · 127 sources
  • drugNeurontin127 co-mentions · 127 sources
  • tagSmall Molecule120 co-mentions · 120 sources
  • companyActavis Elizabeth LLC18 co-mentions · 18 sources
  • companyStrides Pharma Inc13 co-mentions · 13 sources
  • tagRecall7 co-mentions · 7 sources
  • companySun Pharmaceutical Industries Ltd6 co-mentions · 2 sources

indications

investigational
Epilepsy

all catalysts(59)

approval · 59
Sep 12, 2003
approval
23y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 6, 2005
approval
22y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 8, 2005
approval
22y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 23, 2005
approval
21y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 5, 2006
approval
20y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
May 13, 2010
approval
17y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Feb 11, 2011
approval
16y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jun 24, 2011
approval
15y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jun 24, 2011
approval
15y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Aug 30, 2011
approval
15y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 11, 2012
approval
15y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 11, 2012
approval
15y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Aug 28, 2012
approval
14y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Nov 8, 2014
approval
12y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Nov 8, 2014
approval
12y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Mar 16, 2015
approval
12y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 13, 2016
approval
11y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 13, 2016
approval
11y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Mar 24, 2017
approval
10y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
May 14, 2018
approval
9y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 16, 2018
approval
8y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 21, 2020
approval
6y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 21, 2020
approval
6y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Sep 16, 2020
approval
6y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Sep 16, 2020
approval
6y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 2, 2020
approval
6y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 2, 2020
approval
6y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 28, 2020
approval
6y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 28, 2020
approval
6y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 28, 2020
approval
6y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 28, 2020
approval
6y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 28, 2020
approval
6y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 26, 2021
approval
6y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Sep 9, 2021
approval
5y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Feb 20, 2024
approval
3y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 16, 2024
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 16, 2024
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 16, 2024
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 16, 2024
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 16, 2024
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Sep 9, 2024
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Oct 3, 2024
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 19, 2024
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 19, 2024
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 19, 2024
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 19, 2024
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 7, 2025
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 7, 2025
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Feb 4, 2025
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Feb 4, 2025
approval
2y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 21, 2025
approval
1y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jul 21, 2025
approval
1y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Sep 19, 2025
approval
1y ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Nov 24, 2025
approval
12mo ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Dec 17, 2025
approval
11mo ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 29, 2026
approval
10mo ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Jan 29, 2026
approval
10mo ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Mar 6, 2026
approval
9mo ago
GABAPENTIN — FDA approval
GABAPENTIN
→
Apr 2, 2026
approval
8mo ago
GABAPENTIN — FDA approval
GABAPENTIN
→
view all 59 catalysts →

Trials studying GABAPENTIN

  • phase4Abuse Potential of Gabapentin Taken Orally Concomitantly With Oxycodone Hydrochloride in Healthy, Non-Drug-Dependent, Recreational Opioid Usersrecruitingn=60
  • —Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infantsrecruitingn=1,600
  • —A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweatsactive not recruitingn=999
  • phase1A Study on Ketoprofen Lysine Salt (KLS) + Gabapentin (GABA) vs KLS to Investigate Their Pharmacodynamic in Healthy Malescompletedn=141
  • phase4A Study of Oral Dosing of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patientscompletedn=375
  • phase4Post-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients With Moderate Renal Impairmentcompletedn=19
  • phase2Effect of PP-01 on Cannabis Withdrawal Syndromecompletedn=234
  • phase4An Abuse Potential Study of Orally Administered HORIZANT in Healthy, Non-dependent, Recreational Drug Userscompletedn=86

News(1)

  • Most people haven’t heard of kratom. What is it, and who’s using it?
    Few Americans are familiar with kratom, despite public health messaging and rising use. So what is it, and who's using it?
    stat · 12d ago
brand
GABAPENTIN
generic
GABAPENTIN
indication
Partial Seizure
phase
marketed
Data sources
openFDA · ClinicalTrials.gov
last refreshed 5h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?